These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18480702)

  • 1. Galantamine as an adjunctive treatment in major depression.
    Elgamal S; MacQueen G
    J Clin Psychopharmacol; 2008 Jun; 28(3):357-9. PubMed ID: 18480702
    [No Abstract]   [Full Text] [Related]  

  • 2. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.
    Holtzheimer PE; Meeks TW; Kelley ME; Mufti M; Young R; McWhorter K; Vito N; Chismar R; Quinn S; Dey S; Byrd EH; McDonald WM
    Int J Geriatr Psychiatry; 2008 Jun; 23(6):625-31. PubMed ID: 18058832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and tolerability of galantamine in patients with epilepsy and memory difficulties.
    Griffith HR; Martin R; Andrews S; LeBron Paige A; Ware J; Faught E; Welty T
    Epilepsy Behav; 2008 Aug; 13(2):376-80. PubMed ID: 18556248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: case report.
    Cossu G; Melis M; Melis G; Maccioni E; Putzu V; Catte O; Putzu PF
    Mov Disord; 2004 Oct; 19(10):1243-4. PubMed ID: 15389998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Easing the burden of treatment-resistant depression.
    J Clin Psychiatry; 2009 Feb; 70(2):273-80. PubMed ID: 19265643
    [No Abstract]   [Full Text] [Related]  

  • 6. A case report of paranoid delusion with galantamine use.
    Iraqi A; Hughes TL
    J Am Geriatr Soc; 2005 Nov; 53(11):2036-7. PubMed ID: 16274397
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacotherapy of a patient with Alzheimer's disease: interactions with the antidementive galantamine].
    Schwalbe O; Wunderlich S; Kloft C
    Med Monatsschr Pharm; 2006 Jun; 29(6):222-4. PubMed ID: 16792199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galantamine in frontotemporal dementia and primary progressive aphasia.
    Kertesz A; Morlog D; Light M; Blair M; Davidson W; Jesso S; Brashear R
    Dement Geriatr Cogn Disord; 2008; 25(2):178-85. PubMed ID: 18196898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complete atrioventricular block during galantamine therapy].
    Leentjens AF; Kragten JA
    Ned Tijdschr Geneeskd; 2006 Mar; 150(10):563-6. PubMed ID: 16566422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complete atrioventricular block during galantamine therapy].
    Schölzel-Dorenbos CJ
    Ned Tijdschr Geneeskd; 2006 Apr; 150(17):989-90; author reply 990. PubMed ID: 17225744
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of pain on outcomes in a trial of duloxetine treatment of major depressive disorder.
    Arnold LM; Meyers AL; Sunderajan P; Montano CB; Kass E; Trivedi M; Wohlreich MM
    Ann Clin Psychiatry; 2008; 20(4):187-93. PubMed ID: 19034749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight-loss associated with anti-dementia drugs in a patient with Parkinson's disease.
    Gallini A; Sommet A; Salandini AM; Veyssière P; Montastruc JL; Montastruc JL
    Mov Disord; 2007 Oct; 22(13):1980-1. PubMed ID: 17657810
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholinesterase blockers in anesthesiology: a replenishment of former arsenal].
    Buniatian AA; Stamov VI; Mizikov VM; Peĭkarova AV
    Anesteziol Reanimatol; 2011; (1):4-8. PubMed ID: 21513065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyprolidol and imipramine: a double-blind controlled study in endogenous depression.
    Hekimian LJ; Gershon S; Floyd A
    Arzneimittelforschung; 1969 Jun; 19(6):955-6. PubMed ID: 4896165
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of depressed dementia or demented depression].
    Azorin JM
    Encephale; 1994 Jun; 20 Spec No 2():281-4. PubMed ID: 8088247
    [No Abstract]   [Full Text] [Related]  

  • 18. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J; Kavanagh DJ; Deed G; Bone KM
    Hum Psychopharmacol; 2009 Jan; 24(1):41-8. PubMed ID: 19090505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ambulatory treatment of depressions without tranquilizers].
    Ikonomoff SI
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):749-50. PubMed ID: 6415425
    [No Abstract]   [Full Text] [Related]  

  • 20. Electroencephalographic effects of galantamine in major depressive disorder.
    Elgamal SA; Marriott M; Macqueen GM
    J Clin Neurophysiol; 2009 Jun; 26(3):192-7. PubMed ID: 19424085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.